CBD

SARMs and CBD: When food regulation is hard to swallow

SARMs and CBD: Navigating Regulatory Gaps in UK's Food Industry - Unusual products blur the lines between food and medicine, prompting questions about effective regulation.

Can cannabidiol (CBD) treat epilepsy?

Here, OilsBySimpson Founder Kevin William Simpson, explains what current research shows about CBD’s effect on epilepsy and its applications as a treatment.

12 ways you can take cannabidiol (CBD)

Canna CBD Limited shares with us 12 ways you can take cannabidiol (CBD), including oils, tinctures, pills, edibles, as well as products for localised relief like bath salts, lotions, roll-ons and creams.

COVID-19 and medical cannabis: Could the crisis bring opportunities?

John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.

Measuring heavy metals in cannabis and hemp

Here, Robert Thomas, Principal Consultant, Scientific Solutions, highlights the importance of measuring metals in cannabis and hemp.

Cannabinoid products: Create the best organic hemp products for the mass market

A worldwide manufacturer and distributor of cannabinoid products, Elixinol are committed to creating the best organic hemp products for the mass market.

Medical cannabis vaporizers

Vatra Syla, Head of Marketing, Storz & Bickel GmbH & Co. KG, discusses the importance of medical cannabis vaporizers.

EU crackdown: Novel food regulation of CBD

Here, European Union (EU) Novel Food regulations are thoroughly explored and questioned in the context of CBD in food.

Why patient advocates are key to growing CBD brands

Here, we discuss how unregulated industry patient advocates are integral to strengthening the credibility of growing CBD brands.

Up in smoke: Understanding knowledge gaps for cannabis edibles

Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.

The cultivation of sustainable and organic medical cannabis in controlled environments

CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.

Sovereignport discuss their CBD and Hemp supply chain

Speaking with Sarah Yetman, CEO of Sovereignport, we understand how she pioneered a CBD and hemp supply chain that is surviving COVID-19 measures.

Cannyx Markets UK Ltd: The globalisation of the CBD industry

Here, Hassan Akhtar explains how Cannyx Markets UK Ltd. Are successfully navigating the globalisation of the CBD industry.

Professor Mike Barnes: The future of medical cannabis is real

We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.

Setting global standards for CBD quality and compliance

At Mile High Labs, we share a collective vision for global standards of CBD quality and compliance: Let’s discuss the Novel Food application process for the UK.

The FDA’s 2020 Cannabis policy

Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.

Standardised extracts are the future of the CBD industry

Following the latest legislative and market trends, Ilesol Pharmaceuticals has developed a new product with a shiny future in the CBD industry.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders